Stacey L Berg

7PUBLICATIONS
37CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 30, 2025
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.

Sarah Scollon, Sharon E Plon, Steven Joffe

|Sep 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).

Margaret E Macy, Rajen Mody, Joel M Reid

|Sep 19, 2024
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.

Theodore W Laetsch, Kathleen Ludwig, P Mickey Williams

|Oct 03, 2022
A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412.

Kara L Davis, Elizabeth Fox, Emasenyie Isikwei

|Feb 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).

Jennifer H Foster, Stephan D Voss, David C Hall

|Dec 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312).

Kristina A Cole, Sharmistha Pal, Rachel A Kudgus

Pageof 2

Frequent Collaborators

5 joint publications

Elizabeth Fox

4 joint publications

Brenda Weigel

3 joint publications

Katherine A Janeway

3 joint publications

Naoko Takebe